GYRE
Gyre Therapeutics Inc.
7.00$
+4.1%
vs. previous close
Closing price · As of: Oct 9, 2026
Statements
Income Statement
All figures as a percentage of revenue in the same period.
Tick rows to compare them in a chart (up to 4)
| Line item | Q3 16 | Q4 16 | Q1 17 | Q2 17 | Q3 17 | Q4 17 | Q1 18 | Q2 18 | Q3 18 | Q4 18 | Q1 19 | Q2 19 | Q3 19 | Q4 19 | Q1 20 | Q2 20 | Q3 20 | Q4 20 | Q1 21 | Q2 21 | Q3 21 | Q4 21 | Q1 22 | Q2 22 | Q3 22 | Q4 22 | Q1 23 | Q2 23 | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | LTM* |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | – | – | – | – | – | – | – | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | |
| 3,115.6% | 2,974.6% | 10,100.0% | 25,865.8% | 1,196.5% | 9,078.9% | 62,850.0% | – | – | – | – | – | – | – | 27.4% | 105.1% | 102.0% | 102.2% | 100.9% | 104.6% | 104.0% | 100.6% | 114.7% | 0.2% | 4.8% | 4.8% | 4.5% | 3.7% | 3.7% | 4.6% | 3.6% | 3.1% | 3.8% | 4.2% | 4.1% | 3.9% | 5.3% | 4.7% | 5.4% | 7.6% | 5.7% | |
| -3,015.6% | -2,874.6% | -10,000.0% | -25,765.8% | -1,096.5% | -8,978.9% | -62,750.0% | – | – | – | – | – | – | – | 72.6% | -5.1% | -2.0% | -2.2% | -0.9% | -4.6% | -4.0% | -0.6% | -14.7% | -0.2% | 95.2% | 95.2% | 95.5% | 96.3% | 96.3% | 95.4% | 96.4% | 96.9% | 96.2% | 95.8% | 95.9% | 96.1% | 94.7% | 95.3% | 94.6% | 92.4% | 94.3% | |
| 3,115.6% | 4,383.1% | 760.5% | 3,064.0% | 1,196.5% | 1,119.8% | 62,850.0% | – | – | – | – | – | – | – | 81.0% | 778.4% | 1,371.7% | 714.5% | 1,159.7% | 1,355.5% | 881.6% | 661.3% | 1,207.8% | 4.1% | 21.5% | 21.8% | 10.6% | 12.2% | 9.4% | 16.8% | 8.0% | 13.3% | 10.9% | 13.3% | 14.0% | 28.1% | 7.7% | 12.9% | 29.9% | 65.7% | 27.7% | |
| 2,224.8% | 3,069.0% | 878.6% | 2,391.0% | 751.9% | 813.2% | 48,566.7% | – | – | – | – | – | – | – | 22.6% | 263.6% | 429.2% | 211.0% | 368.9% | 399.1% | 211.8% | 170.7% | 252.0% | 8.8% | 23.7% | 24.0% | 7.0% | 5.8% | 3.6% | 37.0% | 12.5% | 13.6% | 15.0% | 19.6% | 22.5% | 24.5% | 14.1% | 18.0% | 32.1% | 27.0% | 21.9% | |
| 5,340.4% | 7,452.1% | 1,639.1% | 5,455.0% | 751.9% | 1,933.0% | 111,416.7% | – | – | – | – | – | – | – | 103.6% | 1,042.0% | 1,800.9% | 925.5% | 1,528.6% | 1,754.6% | 1,093.3% | 831.9% | 1,836.8% | 12.9% | 79.5% | 79.1% | 68.8% | 79.4% | 56.5% | 432.9% | 66.7% | 84.0% | 79.6% | 93.6% | 85.6% | 103.7% | 72.0% | 95.0% | 136.1% | 141.8% | 108.3% | |
| -5,240.4% | -7,352.1% | -1,539.1% | -5,355.0% | -1,848.4% | -1,833.0% | -111,316.7% | – | – | – | – | – | – | – | -31.0% | -1,047.1% | -1,802.9% | -927.7% | -1,529.5% | -1,759.2% | -1,097.4% | -832.5% | -1,851.5% | -13.0% | 15.8% | 16.2% | 26.7% | 17.0% | 39.8% | -337.5% | 29.7% | 12.9% | 16.6% | 2.4% | 10.3% | -7.5% | 22.7% | 0.3% | -41.5% | -49.3% | -14.0% | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | 1.2% | 0.4% | 1.6% | 1.7% | 0.2% | 0.0% | 2.5% | 0.4% | – | – | – | – | – | – | 1.3% | – | – | 3.5% | – | – | – | – | |
| -4,377.1% | -5,281.7% | -1,526.9% | -5,294.6% | -1,821.7% | -1,809.1% | -84,033.3% | – | – | – | – | – | – | – | -24.8% | -1,040.3% | -1,795.4% | -930.9% | -1,529.5% | -1,760.4% | -1,097.8% | -833.2% | -1,830.7% | 117.8% | -3.3% | -4.0% | 25.2% | 20.0% | 34.9% | -369.4% | 45.9% | 23.9% | 15.4% | 2.8% | 21.0% | -5.3% | 25.0% | -0.2% | -41.0% | -49.6% | -13.5% | |
| -828.4% | 2,712.7% | – | – | – | – | -2,816.7% | – | – | – | – | – | – | – | -2.0% | -7.7% | -8.3% | -1.2% | -1.2% | -1.0% | -0.3% | -0.2% | -22.9% | -130.8% | 4.7% | 4.7% | 8.2% | 7.1% | 11.5% | 2.6% | 9.4% | 5.9% | 4.2% | 0.7% | 4.1% | 2.2% | 5.5% | 3.5% | -2.8% | -0.6% | 1.8% | |
| -4,377.1% | -5,281.7% | -1,526.9% | -5,294.6% | -1,821.7% | -1,809.1% | -84,033.3% | – | – | – | – | – | – | – | -24.8% | -1,040.3% | -1,795.4% | -930.9% | -1,529.5% | -1,760.4% | -1,097.8% | -833.2% | -1,830.7% | 117.8% | -11.4% | -12.2% | 9.0% | 6.3% | 12.4% | -372.1% | 27.7% | 14.0% | 4.4% | -0.4% | 12.2% | 2.0% | 11.8% | -4.6% | -38.3% | -36.4% | -14.5% | |
| -4,278.0% | -5,195.8% | -1,521.4% | -5,316.2% | -1,835.5% | -1,820.1% | -110,766.7% | – | – | – | – | – | – | – | -24.6% | -1,038.7% | -1,798.2% | -928.7% | -1,526.4% | -1,756.4% | -1,094.1% | -827.8% | -1,837.3% | -12.9% | -3.3% | -4.0% | 26.3% | 21.0% | 35.5% | -18.0% | 47.5% | 24.9% | 17.3% | 4.1% | 23.4% | -4.1% | 27.1% | 1.7% | -38.0% | -49.4% | -11.7% |
LTM = last twelve months (sum of the four most recent quarters).
Showing the most recent 40 periods — older statements are on file for this stock.
Data as of: October 9, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.